1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Coronavirus Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Corticosteroids 1.2.3 Anti-viral 1.2.4 Monoclonal Antibodies 1.2.5 Kinase Inhibitors 1.2.6 Others 1.3 Market by Application 1.3.1 Global Coronavirus Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Coronavirus Treatment Drugs Market Perspective (2017-2028) 2.2 Coronavirus Treatment Drugs Growth Trends by Region 2.2.1 Coronavirus Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Coronavirus Treatment Drugs Historic Market Size by Region (2017-2022) 2.2.3 Coronavirus Treatment Drugs Forecasted Market Size by Region (2023-2028) 2.3 Coronavirus Treatment Drugs Market Dynamics 2.3.1 Coronavirus Treatment Drugs Industry Trends 2.3.2 Coronavirus Treatment Drugs Market Drivers 2.3.3 Coronavirus Treatment Drugs Market Challenges 2.3.4 Coronavirus Treatment Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Coronavirus Treatment Drugs Players by Revenue 3.1.1 Global Top Coronavirus Treatment Drugs Players by Revenue (2017-2022) 3.1.2 Global Coronavirus Treatment Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Coronavirus Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Coronavirus Treatment Drugs Revenue 3.4 Global Coronavirus Treatment Drugs Market Concentration Ratio 3.4.1 Global Coronavirus Treatment Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Treatment Drugs Revenue in 2021 3.5 Coronavirus Treatment Drugs Key Players Head office and Area Served 3.6 Key Players Coronavirus Treatment Drugs Product Solution and Service 3.7 Date of Enter into Coronavirus Treatment Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Coronavirus Treatment Drugs Breakdown Data by Type 4.1 Global Coronavirus Treatment Drugs Historic Market Size by Type (2017-2022) 4.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2023-2028) 5 Coronavirus Treatment Drugs Breakdown Data by Application 5.1 Global Coronavirus Treatment Drugs Historic Market Size by Application (2017-2022) 5.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Coronavirus Treatment Drugs Market Size (2017-2028) 6.2 North America Coronavirus Treatment Drugs Market Size by Type 6.2.1 North America Coronavirus Treatment Drugs Market Size by Type (2017-2022) 6.2.2 North America Coronavirus Treatment Drugs Market Size by Type (2023-2028) 6.2.3 North America Coronavirus Treatment Drugs Market Share by Type (2017-2028) 6.3 North America Coronavirus Treatment Drugs Market Size by Application 6.3.1 North America Coronavirus Treatment Drugs Market Size by Application (2017-2022) 6.3.2 North America Coronavirus Treatment Drugs Market Size by Application (2023-2028) 6.3.3 North America Coronavirus Treatment Drugs Market Share by Application (2017-2028) 6.4 North America Coronavirus Treatment Drugs Market Size by Country 6.4.1 North America Coronavirus Treatment Drugs Market Size by Country (2017-2022) 6.4.2 North America Coronavirus Treatment Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Coronavirus Treatment Drugs Market Size (2017-2028) 7.2 Europe Coronavirus Treatment Drugs Market Size by Type 7.2.1 Europe Coronavirus Treatment Drugs Market Size by Type (2017-2022) 7.2.2 Europe Coronavirus Treatment Drugs Market Size by Type (2023-2028) 7.2.3 Europe Coronavirus Treatment Drugs Market Share by Type (2017-2028) 7.3 Europe Coronavirus Treatment Drugs Market Size by Application 7.3.1 Europe Coronavirus Treatment Drugs Market Size by Application (2017-2022) 7.3.2 Europe Coronavirus Treatment Drugs Market Size by Application (2023-2028) 7.3.3 Europe Coronavirus Treatment Drugs Market Share by Application (2017-2028) 7.4 Europe Coronavirus Treatment Drugs Market Size by Country 7.4.1 Europe Coronavirus Treatment Drugs Market Size by Country (2017-2022) 7.4.2 Europe Coronavirus Treatment Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Coronavirus Treatment Drugs Market Size (2017-2028) 8.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type 8.2.1 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Coronavirus Treatment Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application 8.3.1 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Coronavirus Treatment Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region 8.4.1 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Coronavirus Treatment Drugs Market Size (2017-2028) 9.2 Latin America Coronavirus Treatment Drugs Market Size by Type 9.2.1 Latin America Coronavirus Treatment Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Coronavirus Treatment Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Coronavirus Treatment Drugs Market Share by Type (2017-2028) 9.3 Latin America Coronavirus Treatment Drugs Market Size by Application 9.3.1 Latin America Coronavirus Treatment Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Coronavirus Treatment Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Coronavirus Treatment Drugs Market Share by Application (2017-2028) 9.4 Latin America Coronavirus Treatment Drugs Market Size by Country 9.4.1 Latin America Coronavirus Treatment Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Coronavirus Treatment Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Coronavirus Treatment Drugs Market Size (2017-2028) 10.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type 10.2.1 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Coronavirus Treatment Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application 10.3.1 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Coronavirus Treatment Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country 10.4.1 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Serum Institute of India 11.1.1 Serum Institute of India Company Details 11.1.2 Serum Institute of India Business Overview 11.1.3 Serum Institute of India Coronavirus Treatment Drugs Introduction 11.1.4 Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.1.5 Serum Institute of India Recent Developments 11.2 Pfizer Inc 11.2.1 Pfizer Inc Company Details 11.2.2 Pfizer Inc Business Overview 11.2.3 Pfizer Inc Coronavirus Treatment Drugs Introduction 11.2.4 Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.2.5 Pfizer Inc Recent Developments 11.3 AstraZeneca Plc 11.3.1 AstraZeneca Plc Company Details 11.3.2 AstraZeneca Plc Business Overview 11.3.3 AstraZeneca Plc Coronavirus Treatment Drugs Introduction 11.3.4 AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.3.5 AstraZeneca Plc Recent Developments 11.4 Bharat Biotech International Limited 11.4.1 Bharat Biotech International Limited Company Details 11.4.2 Bharat Biotech International Limited Business Overview 11.4.3 Bharat Biotech International Limited Coronavirus Treatment Drugs Introduction 11.4.4 Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.4.5 Bharat Biotech International Limited Recent Developments 11.5 Cadila Healthcare Limited 11.5.1 Cadila Healthcare Limited Company Details 11.5.2 Cadila Healthcare Limited Business Overview 11.5.3 Cadila Healthcare Limited Coronavirus Treatment Drugs Introduction 11.5.4 Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.5.5 Cadila Healthcare Limited Recent Developments 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Details 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Coronavirus Treatment Drugs Introduction 11.6.4 Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.6.5 Johnson & Johnson Recent Developments 11.7 Moderna 11.7.1 Moderna Company Details 11.7.2 Moderna Business Overview 11.7.3 Moderna Coronavirus Treatment Drugs Introduction 11.7.4 Moderna Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.7.5 Moderna Recent Developments 11.8 GlaxoSmithKline Plc 11.8.1 GlaxoSmithKline Plc Company Details 11.8.2 GlaxoSmithKline Plc Business Overview 11.8.3 GlaxoSmithKline Plc Coronavirus Treatment Drugs Introduction 11.8.4 GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.8.5 GlaxoSmithKline Plc Recent Developments 11.9 CanSino Biologics 11.9.1 CanSino Biologics Company Details 11.9.2 CanSino Biologics Business Overview 11.9.3 CanSino Biologics Coronavirus Treatment Drugs Introduction 11.9.4 CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.9.5 CanSino Biologics Recent Developments 11.10 Sinovac Biotech 11.10.1 Sinovac Biotech Company Details 11.10.2 Sinovac Biotech Business Overview 11.10.3 Sinovac Biotech Coronavirus Treatment Drugs Introduction 11.10.4 Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.10.5 Sinovac Biotech Recent Developments 11.11 Novavax, Inc 11.11.1 Novavax, Inc Company Details 11.11.2 Novavax, Inc Business Overview 11.11.3 Novavax, Inc Coronavirus Treatment Drugs Introduction 11.11.4 Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.11.5 Novavax, Inc Recent Developments 11.12 Glenmark Pharmaceuticals Limited 11.12.1 Glenmark Pharmaceuticals Limited Company Details 11.12.2 Glenmark Pharmaceuticals Limited Business Overview 11.12.3 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Introduction 11.12.4 Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.12.5 Glenmark Pharmaceuticals Limited Recent Developments 11.13 Dr. Reddy's Laboratories 11.13.1 Dr. Reddy's Laboratories Company Details 11.13.2 Dr. Reddy's Laboratories Business Overview 11.13.3 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Introduction 11.13.4 Dr. Reddy's Laboratories Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.13.5 Dr. Reddy's Laboratories Recent Developments 11.14 Merck & Co., Inc 11.14.1 Merck & Co., Inc Company Details 11.14.2 Merck & Co., Inc Business Overview 11.14.3 Merck & Co., Inc Coronavirus Treatment Drugs Introduction 11.14.4 Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2017-2022) 11.14.5 Merck & Co., Inc Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Coronavirus Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Corticosteroids Table 3. Key Players of Anti-viral Table 4. Key Players of Monoclonal Antibodies Table 5. Key Players of Kinase Inhibitors Table 6. Key Players of Others Table 7. Global Coronavirus Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Coronavirus Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Coronavirus Treatment Drugs Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Coronavirus Treatment Drugs Market Share by Region (2017-2022) Table 11. Global Coronavirus Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Coronavirus Treatment Drugs Market Share by Region (2023-2028) Table 13. Coronavirus Treatment Drugs Market Trends Table 14. Coronavirus Treatment Drugs Market Drivers Table 15. Coronavirus Treatment Drugs Market Challenges Table 16. Coronavirus Treatment Drugs Market Restraints Table 17. Global Coronavirus Treatment Drugs Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Coronavirus Treatment Drugs Revenue Share by Players (2017-2022) Table 19. Global Top Coronavirus Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Treatment Drugs as of 2021) Table 20. Ranking of Global Top Coronavirus Treatment Drugs Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Coronavirus Treatment Drugs Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Coronavirus Treatment Drugs Product Solution and Service Table 24. Date of Enter into Coronavirus Treatment Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Coronavirus Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2017-2022) Table 28. Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2023-2028) Table 30. Global Coronavirus Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Coronavirus Treatment Drugs Revenue Share by Application (2017-2022) Table 32. Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Coronavirus Treatment Drugs Revenue Share by Application (2023-2028) Table 34. North America Coronavirus Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Coronavirus Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Coronavirus Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Coronavirus Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Coronavirus Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Coronavirus Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Coronavirus Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Coronavirus Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Coronavirus Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Coronavirus Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Coronavirus Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Coronavirus Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Coronavirus Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Coronavirus Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Coronavirus Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Coronavirus Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Coronavirus Treatment Drugs Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Coronavirus Treatment Drugs Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Coronavirus Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Coronavirus Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Coronavirus Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Coronavirus Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Coronavirus Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Coronavirus Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Coronavirus Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Coronavirus Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Coronavirus Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Coronavirus Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Coronavirus Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Coronavirus Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 64. Serum Institute of India Company Details Table 65. Serum Institute of India Business Overview Table 66. Serum Institute of India Coronavirus Treatment Drugs Product Table 67. Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 68. Serum Institute of India Recent Developments Table 69. Pfizer Inc Company Details Table 70. Pfizer Inc Business Overview Table 71. Pfizer Inc Coronavirus Treatment Drugs Product Table 72. Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 73. Pfizer Inc Recent Developments Table 74. AstraZeneca Plc Company Details Table 75. AstraZeneca Plc Business Overview Table 76. AstraZeneca Plc Coronavirus Treatment Drugs Product Table 77. AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 78. AstraZeneca Plc Recent Developments Table 79. Bharat Biotech International Limited Company Details Table 80. Bharat Biotech International Limited Business Overview Table 81. Bharat Biotech International Limited Coronavirus Treatment Drugs Product Table 82. Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 83. Bharat Biotech International Limited Recent Developments Table 84. Cadila Healthcare Limited Company Details Table 85. Cadila Healthcare Limited Business Overview Table 86. Cadila Healthcare Limited Coronavirus Treatment Drugs Product Table 87. Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 88. Cadila Healthcare Limited Recent Developments Table 89. Johnson & Johnson Company Details Table 90. Johnson & Johnson Business Overview Table 91. Johnson & Johnson Coronavirus Treatment Drugs Product Table 92. Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 93. Johnson & Johnson Recent Developments Table 94. Moderna Company Details Table 95. Moderna Business Overview Table 96. Moderna Coronavirus Treatment Drugs Product Table 97. Moderna Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 98. Moderna Recent Developments Table 99. GlaxoSmithKline Plc Company Details Table 100. GlaxoSmithKline Plc Business Overview Table 101. GlaxoSmithKline Plc Coronavirus Treatment Drugs Product Table 102. GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 103. GlaxoSmithKline Plc Recent Developments Table 104. CanSino Biologics Company Details Table 105. CanSino Biologics Business Overview Table 106. CanSino Biologics Coronavirus Treatment Drugs Product Table 107. CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 108. CanSino Biologics Recent Developments Table 109. Sinovac Biotech Company Details Table 110. Sinovac Biotech Business Overview Table 111. Sinovac Biotech Coronavirus Treatment Drugs Product Table 112. Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 113. Sinovac Biotech Recent Developments Table 114. Novavax, Inc Company Details Table 115. Novavax, Inc Business Overview Table 116. Novavax, Inc Coronavirus Treatment Drugs Product Table 117. Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 118. Novavax, Inc Recent Developments Table 119. Glenmark Pharmaceuticals Limited Company Details Table 120. Glenmark Pharmaceuticals Limited Business Overview Table 121. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product Table 122. Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 123. Glenmark Pharmaceuticals Limited Recent Developments Table 124. Dr. Reddy's Laboratories Company Details Table 125. Dr. Reddy's Laboratories Business Overview Table 126. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product Table 127. Dr. Reddy's Laboratories Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 128. Dr. Reddy's Laboratories Recent Developments Table 129. Merck & Co., Inc Company Details Table 130. Merck & Co., Inc Business Overview Table 131. Merck & Co., Inc Coronavirus Treatment Drugs Product Table 132. Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2017-2022) & (US$ Million) Table 133. Merck & Co., Inc Recent Developments Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Global Coronavirus Treatment Drugs Market Share by Type: 2021 VS 2028 Figure 2. Corticosteroids Features Figure 3. Anti-viral Features Figure 4. Monoclonal Antibodies Features Figure 5. Kinase Inhibitors Features Figure 6. Others Features Figure 7. Global Coronavirus Treatment Drugs Market Share by Application: 2021 VS 2028 Figure 8. Hospital Pharmacies Case Studies Figure 9. Retail Pharmacies Case Studies Figure 10. Online Pharmacies Case Studies Figure 11. Coronavirus Treatment Drugs Report Years Considered Figure 12. Global Coronavirus Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Coronavirus Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Coronavirus Treatment Drugs Market Share by Region: 2021 VS 2028 Figure 15. Global Coronavirus Treatment Drugs Market Share by Players in 2021 Figure 16. Global Top Coronavirus Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Treatment Drugs as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Coronavirus Treatment Drugs Revenue in 2021 Figure 18. North America Coronavirus Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America Coronavirus Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 20. North America Coronavirus Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 21. North America Coronavirus Treatment Drugs Market Size Share by Country (2017-2028) Figure 22. United States Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Coronavirus Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe Coronavirus Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 26. Europe Coronavirus Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 27. Europe Coronavirus Treatment Drugs Market Size Share by Country (2017-2028) Figure 28. Germany Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Coronavirus Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific Coronavirus Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific Coronavirus Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific Coronavirus Treatment Drugs Market Size Share by Region (2017-2028) Figure 38. China Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America Coronavirus Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America Coronavirus Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 46. Latin America Coronavirus Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 47. Latin America Coronavirus Treatment Drugs Market Size Share by Country (2017-2028) Figure 48. Mexico Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Coronavirus Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa Coronavirus Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa Coronavirus Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa Coronavirus Treatment Drugs Market Size Share by Country (2017-2028) Figure 54. Turkey Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE Coronavirus Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Serum Institute of India Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 58. Pfizer Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 59. AstraZeneca Plc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 60. Bharat Biotech International Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 61. Cadila Healthcare Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 62. Johnson & Johnson Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 63. Moderna Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 64. GlaxoSmithKline Plc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 65. CanSino Biologics Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 66. Sinovac Biotech Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 67. Novavax, Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 68. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 69. Dr. Reddy's Laboratories Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 70. Merck & Co., Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2017-2022) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Serum Institute of India Pfizer Inc AstraZeneca Plc Bharat Biotech International Limited Cadila Healthcare Limited Johnson & Johnson Moderna GlaxoSmithKline Plc CanSino Biologics Sinovac Biotech Novavax, Inc Glenmark Pharmaceuticals Limited Dr. Reddy's Laboratories Merck & Co., Inc